Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
559 hedge funds and large institutions have $11.5B invested in Exact Sciences in 2022 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 189 increasing their positions, 187 reducing their positions, and 84 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
2.86% more ownership
Funds ownership: 93.29% → 96.16% (+2.9%)
1% more repeat investments, than reductions
Existing positions increased: 189 | Existing positions reduced: 187
6% less funds holding
Funds holding: 596 → 559 (-37)
8% less capital invested
Capital invested by funds: $12.5B → $11.5B (-$995M)
20% less call options, than puts
Call options by funds: $128M | Put options by funds: $160M
36% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 84
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$394M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$114M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$90.1M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$60.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$58.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$73.3M |
| 2 |
Amundi
Paris,
France
|
-$62.9M |
| 3 |
CC
Casdin Capital
New York
|
-$51.9M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$38.1M |
| 5 |
National Pension Service
Jeonju-Si, Jeollabuk-Do,
South Korea
|
-$22.1M |
EXAS Hedge Fund Activity: Q1 2022 in Review
559 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2022, worth a combined $11.5B — down 8% from $12.5B a quarter earlier.
Sellers outnumbered buyers: 84 funds closed out of EXAS and 54 opened new positions — a net loss of 30 holders — while 187 trimmed existing stakes and 189 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $394M. The largest seller was Ameriprise, cutting an estimated $73.3M.
- 559 institutional investors held Exact Sciences (EXAS) as of Q1 2022, down from 596 in Q4 2021.
- Funds reported $11.5B of Exact Sciences stock for Q1 2022, down 8% quarter-over-quarter.
- 54 funds opened new Exact Sciences positions in Q1 2022 and 84 closed out, a net change of -30 holders.
- The largest Exact Sciences buyer in Q1 2022 was T. Rowe Price Associates, an estimated $394M added.
- The largest Exact Sciences seller in Q1 2022 was Ameriprise, an estimated $73.3M sold.
Based on aggregated 13F filings for Q1 2022.